Global Nerve Growth Factor (NGF) Market
Global Nerve Growth Factor (NGF) Market
was valued $XX Mn in 2019 and is expected to reach $XX Mn by 2026, at a CAGR of XX% during forecast period.
Global Nerve Growth Factor (NGF) Market Overview:
Nerve growth factor (NGF) is a neurotrophic protein, which is primarily involved in the regulation of growth, maintenance, proliferation, and survival of certain target neurons.It is known to play a critical protective role in the development and survival of sympathetic, sensory and forebrain cholinergic neurons.
Global Nerve Growth Factor (NGF) Market Dynamics:
Growing cases of various neurological disorders, corneal ulcer and other autoimmune diseases are the main factors driving the market growth. Neurological disorders like Alzheimer’s disease and other diseases like a corneal ulcer, various autoimmune diseases present globally are responsible for damaging the tissue of the immune system. This factor primarily drives the Nerve Growth Factor market. Alzheimer's is most prevalent in the US, where approximately 5.5 million people are affected, and the prevalence worldwide is estimated to be as high as 24 million. Along with this, increased government funding, and ongoing research studies for the development of novel treatments using NGF for the treatment of various diseases will also boost the market growth. Another advantage of NGF such as it controls the regulation of the nervous system in embryos and regulates the growth, function & repair of neurons in adults, and nerve cell recovery after surgical or chemical injuries helps in stimulating the growth of the market. The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Global Nerve Growth Factor (NGF) Market Segment Analysis:
The global Nerve Growth Factor Market is segmented on the basis of Type, Application and End-Users. Based on Application, the nerve growth factor market segmented into neurodegenerative disorders, spinal cord injuries, tissue healing, and autoimmune diseases. Neurodegenerative disorders segment is expected to dominate the market owing to numerous studies which have shown that NGF contributes to the survival and regeneration of neurons during aging and in age-related diseases such as Alzheimer’s.
To Know About The Research Methodology :- Request Free Sample Report
Global Nerve Growth Factor (NGF) Market Regional Insights:
North America is expected to account for highest market share during forecast period. The presence of advanced technology and favourable reimbursement policies offered by the government encourages the growth of the market in the region. Besides this, the high prevalence of the population suffering from neurodegenerative disorders, ongoing R&D activities for novel treatment development, and high healthcare expenditure contribute to the market growth. Europe is considered the second-largest market for nerve growth factor due to strategic collaboration between academic research institute and pharmaceutical giants to develop new drugs. The report also helps in understanding Global Nerve Growth Factor (NGF) Market dynamics, structure by analyzing the market segments and project the Global Nerve Growth Factor (NGF) Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nerve Growth Factor (NGF) Market make the report investor’s guide.
Global Nerve Growth Factor (NGF) Market Scope: Inquire before buying
Global Nerve Growth Factor (NGF) Market, by Region:
• North America • Europe • South America • MEA • APAC
Global Nerve Growth Factor (NGF) Market Key players:
• Dompe farmaceutici S.p.A. • Pfizer Inc • Regeneron • Astellas Pharma Inc. • Merck KGaA • Promega Corporation • Alomone Labs • Bio-Rad Laboratories, Inc. • Enzo Life Sciences, Inc. • Prospec-Tany Technogene Ltd. • CUSABIO TECHNOLOGY LLC • Biocare Medical, LLC. • Eli Lilly & Company • Teva Pharmaceutical Industries • Mitsubishi Tanabe Pharma Corporation
